Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PF-06939926
PF-06939926
Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment
Fierce Biotech
Tue, 12/21/21 - 10:28 am
Pfizer
clinical trials
Duchenne Muscular Dystrophy
gene therapy
patient deaths
PF-06939926
FDA Grants Fast Track Designation to Pfizer's DMD Gene Therapy
BioSpace
Fri, 10/2/20 - 12:41 pm
Pfizer
fast track
FDA
Duchenne Muscular Dystrophy
PF-06939926
Safety questions linger as Pfizer preps Duchenne gene therapy for final test
BioPharma Dive
Fri, 05/15/20 - 10:20 am
Pfizer
gene therapy
Duchenne Muscular Dystrophy
PF-06939926
Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study
Yahoo/Zacks.com
Mon, 07/1/19 - 10:16 am
Pfizer
DMD
Duchenne Muscular Dystrophy
clinical trials
gene therapy
PF-06939926
Pfizer Commences Ph Ib Trial With Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
CP Wire
Thu, 04/12/18 - 11:51 am
Pfizer
PF-06939926
Duchenne Muscular Dystrophy
gene therapy